ScholarIQanswers from OpenAlex & ORCID
Ute Hegenbart
ResearcherPublications, citations & collaboration network
Ute Hegenbart is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ute Hegenbart have?
ScholarIQindexed works
Ute Hegenbart has 488 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ute Hegenbart have?
ScholarIQcitation count
Ute Hegenbart has 17,157 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ute Hegenbart?
ScholarIQh-index
Ute Hegenbart has an h-index of 66 in OpenAlex.
What is the i10-index of Ute Hegenbart?
ScholarIQi10-index
Ute Hegenbart has an i10-index of 214 in OpenAlex.
What is the ORCID of Ute Hegenbart?
ScholarIQorcid
The ORCID for Ute Hegenbart is on the source record.
What is the OpenAlex record for Ute Hegenbart?
ScholarIQopenalex
The OpenAlex for Ute Hegenbart is on the source record.
What are the most-cited papers on Ute Hegenbart?
ScholarIQmost cited works
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
Peter A. McSweeney, Dietger Niederwieser, Judith A. Shizuru, Brenda M. Sandmaier, Arthur J. Molina, David G. Maloney, Thomas R. Chauncey, Theodore A. Gooley, Ute Hegenbart, Richard A. Nash, Jerald P. Radich, John L. Wagner, Steven T. Minor, Frederick R. Appelbaum, William Bensinger, Eileen Bryant, Mary E.D. Flowers, George E. Georges, F. Carl Grumet, Hans‐Peter Kiem, Beverly Torok‐Storb, Cong Yu, Karl G. Blume, Rainer Storb
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial
Peter Dreger, Hartmut Döhner, Matthias Ritgen, Sebastian Böttcher, Raymonde Busch, Sascha Dietrich, Donald Bunjes, Sandra Cohen, Jörg Schubert, Ute Hegenbart, Dietrich W. Beelen, Matthias Zeis, Michael Stadler, Justin Hasenkamp, Lutz Uharek, Christof Scheid, Andreas Humpe, Thorsten Zenz, Dirk Winkler, Michael Hallek, Michael Kneba, Norbert Schmitz, Stephan Stilgenbauer, for the German CLL Study Group